Search research articles
Contact Us
Filters
Showing results (261-270 of 316) with videos related to
Page
of 32
Sort By:
British Journal of Cancer
|
January 1, 1997
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines
R E Banks, M A Forbes, S Hallam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 2008
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer
P M Patel, S Sim, D O O'Donnell, et al.
Kidney International
|
June 7, 2013
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation
Matthew P Welberry Smith, Alexandre Zougman, David A Cairns, et al.
Molecular Human Reproduction
|
June 10, 1998
Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1
R E Banks, M A Forbes, J Searles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2004
Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
S Winawer, J Faivre, J Selby, et al.
Plos One
|
September 10, 2016
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
Mark J Selby, John J Engelhardt, Robert J Johnston, et al.
Plos One
|
November 19, 2016
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
Mark J Selby, John J Engelhardt, Robert J Johnston, et al.
Cytokine
|
May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects
R E Banks, M A Forbes, P M Patel, et al.
British Journal of Haematology
|
March 22, 2001
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
F E Davies, P D Forsyth, A C Rawstron, et al.
British Journal of Urology
|
May 1, 1996
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation
J K Joffe, R E Banks, M A Forbes, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 316) with videos related to
Sort By:
Page
of 32
British Journal of Cancer
|
January 1, 1997
Treatment of metastatic renal cell carcinoma with subcutaneous interleukin 2: evidence for non-renal clearance of cytokines
R E Banks, M A Forbes, S Hallam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 2008
An evaluation of a preparation of Mycobacterium vaccae (SRL172) as an immunotherapeutic agent in renal cancer
P M Patel, S Sim, D O O'Donnell, et al.
Kidney International
|
June 7, 2013
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation
Matthew P Welberry Smith, Alexandre Zougman, David A Cairns, et al.
Molecular Human Reproduction
|
June 10, 1998
Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1
R E Banks, M A Forbes, J Searles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2004
Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
S Winawer, J Faivre, J Selby, et al.
Plos One
|
September 10, 2016
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
Mark J Selby, John J Engelhardt, Robert J Johnston, et al.
Plos One
|
November 19, 2016
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
Mark J Selby, John J Engelhardt, Robert J Johnston, et al.
Cytokine
|
May 11, 2000
Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects
R E Banks, M A Forbes, P M Patel, et al.
British Journal of Haematology
|
March 22, 2001
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
F E Davies, P D Forsyth, A C Rawstron, et al.
British Journal of Urology
|
May 1, 1996
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation
J K Joffe, R E Banks, M A Forbes, et al.
Page
of 32